Kinetic analysis of agonist-induced down-regulation of the beta(2)-adrenergic receptor in BEAS-2B cells reveals high- and low-affinity components.

We examined the interrelationships of internalization and down-regulation of the beta(2)-adrenergic receptor in response to treatment of the BEAS-2B human epithelial cell line with both a series of agonists at high occupancy and with various concentrations of fenoterol that gave occupancies from 0.93 to 0.001. We found that the extent of internalization measured after a 30-min treatment increased as a function of coupling efficiency, with ephedrine, dobutamine, albuterol, fenoterol, and epinephrine giving 0, 7, 17, 48, and 55% internalization, respectively. With the exception of dobutamine, the rates of down-regulation (k(deg)) also showed a dependence on agonist coupling efficiency, giving (in terms of fraction of receptors lost/h) 0.082 with ephedrine, 0.250 with dobutamine, 0.148 with albuterol, 0.194 with fenoterol, and 0.212 with epinephrine. Comparison of down-regulation to internalization showed that weak agonists caused down-regulation in the absence of significant internalization. The extent of internalization caused by fenoterol over a 1000-fold range of occupancy was proportional to agonist occupancy. However, although no internalization was observed with the low concentrations (0.2 and 2 nM fenoterol), these concentrations did cause significant down-regulation. Thus, as with partial agonists, it was clear that down-regulation occurred in the absence of measurable internalization. The kinetics of agonist-induced down-regulation are consistent with a scheme in which down-regulation proceeds by two pathways; a high-affinity, low-capacity component (EC(50) = 0.5 nM) clearly dissociated from internalization and a low-affinity, high-capacity component (EC(50) = 160 nM) closely correlated with internalization.

[1]  A. Seibold,et al.  β2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial Agonists* , 1997, The Journal of Biological Chemistry.

[2]  J. Friedman,et al.  Desensitization of β2-Adrenergic Receptors with Mutations of the Proposed G Protein-coupled Receptor Kinase Phosphorylation Sites* , 1998, The Journal of Biological Chemistry.

[3]  J. Edwardson,et al.  Endocytosis and recycling of G protein-coupled receptors. , 1997, Trends in pharmacological sciences.

[4]  Wei‐Ting Chang,et al.  Down-regulation of β-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure , 1993 .

[5]  R. Butcher,et al.  Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine. , 1992, Molecular pharmacology.

[6]  R. Lefkowitz,et al.  G protein-coupled receptor kinases. , 1998, Annual review of biochemistry.

[7]  M. Caron,et al.  Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. , 1989, The Journal of biological chemistry.

[8]  B. J. Knoll,et al.  Agonist-induced sorting of human beta2-adrenergic receptors to lysosomes during downregulation. , 1999, Journal of cell science.

[9]  R. Lefkowitz,et al.  Mechanisms of Ligand-Induced Desensitization of Beta-Adrenergic Receptors , 1991 .

[10]  M. Caron,et al.  From ligand binding to gene expression: new insights into the regulation of G-protein-coupled receptors. , 1992, Trends in biochemical sciences.

[11]  L. Birnbaumer,et al.  Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. , 1994, Molecular pharmacology.

[12]  B. J. Knoll,et al.  Salmeterol‐induced desensitization, internalization and phosphorylation of the human β2‐adrenoceptor , 1998, British journal of pharmacology.

[13]  L. Tsai,et al.  Down-regulation of beta-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure. , 1993, European heart journal.

[14]  B. J. Knoll,et al.  Partial agonists and G protein-coupled receptor desensitization. , 1999, Trends in pharmacological sciences.

[15]  R Barber,et al.  Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution. , 1996, Molecular pharmacology.

[16]  P. Molinoff,et al.  Relationship between intrinsic activities of agonists in normal and desensitized tissue and agonist-induced loss of beta adrenergic receptors. , 1984, Journal of Pharmacology and Experimental Therapeutics.

[17]  S. Kelsen,et al.  Regulation of beta-agonist- and prostaglandin E2-mediated adenylyl cyclase activity in human airway epithelial cells. , 1994, American journal of respiratory cell and molecular biology.

[18]  J L Benovic,et al.  Role of Clathrin-mediated Endocytosis in Agonist-induced Down-regulation of the β2-Adrenergic Receptor* , 1998, The Journal of Biological Chemistry.

[19]  A. Strosberg,et al.  Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis. , 1999, The Journal of biological chemistry.

[20]  J. Edwardson,et al.  Kinetic analysis of the trafficking of muscarinic acetylcholine receptors between the plasma membrane and intracellular compartments. , 1994, The Journal of biological chemistry.

[21]  J. Benovic,et al.  The role of receptor kinases and arrestins in G protein-coupled receptor regulation. , 1998, Annual review of pharmacology and toxicology.

[22]  S. Kelsen,et al.  Chronic effects of catecholamines on the beta 2-adrenoreceptor system in cultured human airway epithelial cells. , 1997, The American journal of physiology.

[23]  C. Londos,et al.  A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.